Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer.


Journal

International journal of oncology
ISSN: 1791-2423
Titre abrégé: Int J Oncol
Pays: Greece
ID NLM: 9306042

Informations de publication

Date de publication:
07 2020
Historique:
received: 18 11 2019
accepted: 05 03 2020
pubmed: 23 4 2020
medline: 9 3 2021
entrez: 23 4 2020
Statut: ppublish

Résumé

Tertiary lymphoid structures (TLSs), which consist of B cells, T cells, follicular dendritic cells and high endothelial venules, have recently been found to be associated with effective antitumor immune responses in patients with cancer. Tumor‑infiltrating T cells and B cells have each been demonstrated to be associated with survival in patients with cancer. We hypothesized that TLSs, an assembly of immune cells, may be important for the initiation and/or maintenance of T cell and B cell responses against tumors. The aim of the present study was to examine the cellular mechanism of B cells in TLSs within gastric cancer and to understand the antitumor immune response of TLSs. Each B cell subset in a tumor was examined using flow cytometry to evaluate B cell differentiation and the functional status of B cells. In addition, B cell clonality was investigated by analyzing the B cell antigen receptor gene using PCR, and the function and formation/maintenance of TLSs were evaluated using reverse transcription‑quantitative PCR. Tumor‑infiltrating B cells were more differentiated compared with that in distant non‑tumor tissues and tumor‑draining lymph nodes. The PCR results revealed specific BCR gene expression in tumor‑infiltrating B cells. The expression of co‑stimulatory factors, CD80 and CD86, was observed, in addition to the constantly expressed major histocompatibility complex molecules (HLA‑ABC and HLA‑DR). CD70 was expressed in addition to CD27 in both CD20+ B cells and CD8+ T cells, indicating that these factors are activated together through their interaction. The mRNA expression levels of CCL21, CXCL13, PD‑L1, perforin and granzyme B in TLSs was significantly higher compared with that in non‑TLSs. The majority of tumor‑infiltrating B cells in gastric cancer exist in the form of TLSs around the tumor and have been antigen‑sensitized and differentiated, and proliferated in TLSs but not in the lymph nodes. In addition, B cells in TLSs might primarily function as antigen‑presenting cells and be associated with the induction of cytotoxic T cells.

Identifiants

pubmed: 32319601
doi: 10.3892/ijo.2020.5042
pmc: PMC7252463
doi:

Substances chimiques

Antigens, Neoplasm 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

171-182

Références

Inflamm Res. 2009 Jul;58(7):345-57
pubmed: 19262989
Am J Transplant. 2007 May;7(5):1071-9
pubmed: 17359505
J Immunol Methods. 1995 Feb 27;179(2):203-14
pubmed: 7876568
Immunity. 2015 Apr 21;42(4):607-12
pubmed: 25902480
Clin Cancer Res. 2008 Aug 15;14(16):5220-7
pubmed: 18698040
Br J Cancer. 2013 Sep 17;109(6):1676-84
pubmed: 23982600
Immunol Rev. 2016 May;271(1):260-75
pubmed: 27088920
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Cancer Lett. 2013 Jun 10;333(2):222-8
pubmed: 23370224
Cancer Res. 2008 Jul 1;68(13):5405-13
pubmed: 18593943
Clin Cancer Res. 2012 Jun 15;18(12):3281-92
pubmed: 22553348
Front Immunol. 2015 Feb 23;6:67
pubmed: 25755654
Cancers (Basel). 2014 Apr 23;6(2):969-97
pubmed: 24762633
J Immunol. 2005 Aug 1;175(3):1665-76
pubmed: 16034107
Immunotherapy. 2015;7(6):655-67
pubmed: 26098609
Gastric Cancer. 2011 Jun;14(2):101-12
pubmed: 21573743
J Surg Res. 2017 Jul;215:74-82
pubmed: 28688665
Blood. 2011 Aug 11;118(6):1560-9
pubmed: 21659539
Semin Immunol. 2008 Feb;20(1):26-42
pubmed: 18243731
Cancer Immunol Immunother. 2013 Mar;62(3):405-10
pubmed: 23423351
Br J Cancer. 2008 Nov 18;99(10):1704-11
pubmed: 18941457
Front Immunol. 2019 Aug 22;10:1884
pubmed: 31507584
Clin Cancer Res. 2013 Nov 1;19(21):5994-6005
pubmed: 24056784
Front Immunol. 2019 Jun 20;10:1398
pubmed: 31281318
Am J Surg Pathol. 2010 Jul;34(7):1019-24
pubmed: 20505498
Immunol Rev. 2018 May;283(1):138-149
pubmed: 29664566
Trends Immunol. 2014 Nov;35(11):571-80
pubmed: 25443495
J Exp Med. 2004 Jun 7;199(11):1595-605
pubmed: 15184507
Oncoimmunology. 2015 Jun 3;5(2):e1054598
pubmed: 27057426
BMC Clin Pathol. 2014 Aug 23;14:38
pubmed: 25177210
Immunol Cell Biol. 2012 Apr;90(4):457-67
pubmed: 21808264
J Immunol. 2009 Aug 1;183(3):1838-45
pubmed: 19592644
Nat Rev Immunol. 2003 Apr;3(4):292-303
pubmed: 12669020
J Immunol. 2008 Feb 1;180(3):1362-72
pubmed: 18209030
Clin Cancer Res. 2016 Jun 15;22(12):3005-15
pubmed: 26763251
Nat Rev Immunol. 2008 Jan;8(1):22-33
pubmed: 18097447
Methods Mol Biol. 2019;1960:93-99
pubmed: 30798524
Clin Exp Metastasis. 2016 Oct;33(7):727-39
pubmed: 27449756
Curr Opin Immunol. 2005 Jun;17(3):275-81
pubmed: 15886117
Int J Cancer. 2016 Sep 1;139(5):1129-39
pubmed: 27074317
J Mol Med (Berl). 2010 Nov;88(11):1169-80
pubmed: 20798913
World J Gastroenterol. 2006 Jan 21;12(3):354-62
pubmed: 16489633
Am J Respir Crit Care Med. 2014 Apr 1;189(7):832-44
pubmed: 24484236
Front Immunol. 2016 Oct 03;7:407
pubmed: 27752258
BMC Cancer. 2015 Mar 06;15:101
pubmed: 25884667
Trends Immunol. 2012 Jun;33(6):297-305
pubmed: 22622061
J Exp Med. 1994 Jul 1;180(1):329-39
pubmed: 8006591

Auteurs

Yoshihito Yamakoshi (Y)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Abeno‑ku, Osaka 545‑8585, Japan.

Hiroaki Tanaka (H)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Abeno‑ku, Osaka 545‑8585, Japan.

Chie Sakimura (C)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Abeno‑ku, Osaka 545‑8585, Japan.

Sota Deguchi (S)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Abeno‑ku, Osaka 545‑8585, Japan.

Takuya Mori (T)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Abeno‑ku, Osaka 545‑8585, Japan.

Tatsuro Tamura (T)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Abeno‑ku, Osaka 545‑8585, Japan.

Takahiro Toyokawa (T)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Abeno‑ku, Osaka 545‑8585, Japan.

Kazuya Muguruma (K)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Abeno‑ku, Osaka 545‑8585, Japan.

Kosei Hirakawa (K)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Abeno‑ku, Osaka 545‑8585, Japan.

Masaichi Ohira (M)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Abeno‑ku, Osaka 545‑8585, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH